logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Tuoxin Pharmaceutical: The company's coenzyme Q10 raw material products are actively expanding into the pharmaceutical-grade market.

date
10/04/2026
Tuoxin Pharmaceutical stated on the interactive platform on April 10th that the company's coenzyme Q10 raw material products are currently mainly sold as food grade, and the company is actively expanding into the pharmaceutical grade market.
Latest
5 m ago
Li Changyong: The US dollar to South Korean won exchange rate is expected to reach close to 1500 by the end of 2025, mainly due to the increase in overseas stock investments by retail investors.
5 m ago
The Nikkei 225 index closed up 1.5% in early trading at 56728.95 points, while the Topix index closed down 0.04% at 3739.99 points.
6 m ago
Lee Chang-yeong: Incoming Bank of Korea Governor Shin Hyun-song owning overseas assets will not pose a major problem.
7 m ago
Spot gold lost the 4740 US dollars per ounce mark and fell 0.54% intra-day.
8 m ago
Xie Lei, a second-level researcher at the Anhui Wuhu High-tech Industrial Development Zone Management Committee, is under review and investigation.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.